Business School Hosts Industry Executives
Brian Waterman ’86, Executive Vice Chairman at Newmark, Frank Mangano ’88, COO and CFO of Havas North America, and Rich Lacourciere ’87, Chief Revenue...
National Non-Profit Welcomes Diversity & Inclusion Specialist
Lesly St. Louis ’10 joined the United Spinal Association as director of employment and DEI programs, where he assists people with spinal cord injuries...
Banking Expert Selected as Senior Vice President
Joel Barnett ’97 joined Fulton Bank in Pennsylvania as its new senior vice president and director of commercial affinity banking, where he will focus...
Smithsonian Researcher Named Senior Scientist
Dr. Katrina Lohan, ’04, was appointed Senior Scientist at the Marine Disease Ecology Laboratory within the Smithsonian Environmental Research Center. Dr. Lohan specializes in...
Honors Student’s Cancer Research Published in Medical Journal
Biochemistry major Julia Zebak co-authored her first peer-reviewed article in Radiotherapy and Oncology titled “Patterns and Predictors of Relapse in Merkel Cell Carcinoma: Results from a...
Research Ranks LIU as “Best College”
Research.com, a leading academic platform, included LIU on its list of “Best Colleges.” The rankings feature colleges and universities across the country that provide...
Expanding Financial Tech Company Adds New Vice President
Michael Baez ’88, ’91 was selected as the vice president of professional services and customer strategy for Leasepath, a cloud-based intelligent workplace finance organization...
JPMorgan Chase Partnership Establishes Financial Health Course
JPMorgan Chase has partnered with the Roc Nation School of Music, Sports & Entertainment to provide tuition support and establish the School's first-ever financial...
WNBC Recognizes Philanthropic Service
Heather Butts, Co-Director of the Honors College, is helping provide food for those in need through her volunteer efforts with Little Free Library, a...
Weinand Named Chairman at Replimune Group
Dieter Weinand (MS ’87) was appointed Chairman of the Board of Directors at Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene therapies....